MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Guido Moll, Norman Drzeniek, Julian Kamhieh-Milz, Sven Geissler, Hans-Dieter Volk, Petra Reinke

Journal title: Frontiers in Immunology

Journal number: 11

Journal publisher: Frontiers Media S.A.

Published year: 2020

DOI identifier: 10.3389/fimmu.2020.01091

ISSN: 1664-3224